Circular RNA coiled-coil domain containing 66 regulates malignant development of papillary thyroid carcinoma by upregulating La ribonucleoprotein 1 via the sponge effect on miR-129-5p

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019 Jan;69(1):7–34.
   PubMed Web of Science ®Google Scholar
• Fillon M. Both leading molecular thyroid tests may reduce the need for diagnostic surgery. CA Cancer J Clin. 2021 May;71(3):193–194.
   PubMed Web of Science ®Google Scholar
• Miranda-Filho A, Lortet-Tieulent J, Bray F, et al. Thyroid cancer incidence trends by histology in 25 countries: a population-based study. Lancet Diabetes Endocrinol. 2021 Apr;9(4):225–234.
   PubMed Web of Science ®Google Scholar
• Rossi ED, Pantanowitz L, Hornick JL. A worldwide journey of thyroid cancer incidence centred on tumour histology. Lancet Diabetes Endocrinol. 2021 Apr;9(4):193–194.
   PubMed Web of Science ®Google Scholar
• Morton LM, Karyadi DM, Stewart C, et al. Radiation-related genomic profile of papillary thyroid carcinoma after the Chernobyl accident. Science. 2021 May 14;372(6543). 10.1126/science.abg2538.
   PubMed Web of Science ®Google Scholar
• Krishnan A, Berthelet J, Renaud E, et al. Proteogenomics analysis unveils a TFG-RET gene fusion and druggable targets in papillary thyroid carcinomas. Nat Commun. 2020 Apr 28;11(1):2056.
   PubMed Web of Science ®Google Scholar
• Samimi H, Haghpanah V. Gut microbiome and radioiodine-refractory papillary thyroid carcinoma pathophysiology. Trends Endocrinol Metab. 2020 Sep;31(9):627–630.
   PubMed Web of Science ®Google Scholar
• Lee SH, Roh JL, Gong G, et al. Risk factors for recurrence after treatment of N1b papillary thyroid carcinoma. Ann Surg. 2019 May;269(5):966–971.
   PubMed Web of Science ®Google Scholar
• Angell TE, Lechner MG, Jang JK, et al. MHC class I loss is a frequent mechanism of immune escape in papillary thyroid cancer that is reversed by interferon and selumetinib treatment in vitro. Clin Cancer Res. 2014 Dec 1; 20(23):6034–6044.
   PubMed Web of Science ®Google Scholar
• Adam MA, Pura J, Gu L, et al. Extent of surgery for papillary thyroid cancer is not associated with survival: an analysis of 61,775 patients. Ann Surg. discussion 5-7. 2014 Oct;260(4):601–605.
   PubMed Web of Science ®Google Scholar
• Di Maro G, Salerno P, Unger K, et al. Anterior gradient protein 2 promotes survival, migration and invasion of papillary thyroid carcinoma cells. Mol Cancer. 2014 Jun 30;13(1):160.
   PubMedGoogle Scholar
• Okholm TLH, Sathe S, Park SS, et al. Transcriptome-wide profiles of circular RNA and RNA-binding protein interactions reveal effects on circular RNA biogenesis and cancer pathway expression. Genome Med. 2020 Dec 7;12(1):112.
   PubMed Web of Science ®Google Scholar
• Schreiner S, Didio A, Hung LH, et al. Design and application of circular RNAs with protein-sponge function. Nucleic Acids Res. 2020 Dec 2; 48(21):12326–12335.
   PubMed Web of Science ®Google Scholar
• Wen G, Zhou T, Gu W. The potential of using blood circular RNA as liquid biopsy biomarker for human diseases. Protein Cell. 2020 Nov 1; 12(12):911–946.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang Y, Wang P, et al. Circular RNAs in renal cell carcinoma: implications for tumorigenesis, diagnosis, and therapy. Mol Cancer. 2020 Oct 14; 19(1):149.
   PubMed Web of Science ®Google Scholar
• Gokool A, Loy CT, Halliday GM, et al. Circular RNAs: the brain transcriptome comes full circle. Trends Neurosci. 2020 Oct;43(10):752–766.
   PubMed Web of Science ®Google Scholar
• Xu T, Wang M, Jiang L, et al. CircRNAs in anticancer drug resistance: recent advances and future potential. Mol Cancer. 2020 Aug 17;19(1):127.
   PubMed Web of Science ®Google Scholar
• Ma C, Wang X, Yang F, et al. Circular RNA hsa_circ_0004872 inhibits gastric cancer progression via the miR-224/Smad4/ADAR1 successive regulatory circuit. Mol Cancer. 2020 Nov 10;19(1):157.
   PubMed Web of Science ®Google Scholar
• Peng L, Sang H, Wei S, et al. Circcul2 regulates gastric cancer malignant transformation and cisplatin resistance by modulating autophagy activation via miR-142-3p/ROCK2. Mol Cancer. 2020 Nov 5;19(1):156.
   PubMed Web of Science ®Google Scholar
• Saaoud F, Drummer IVC, Shao Y, et al. Circular RNAs are a novel type of non-coding RNAs in ROS regulation, cardiovascular metabolic inflammations and cancers. Pharmacol Ther. 2020 Oct 24;220:107715.
   PubMed Web of Science ®Google Scholar
• Muhammad N, Bhattacharya S, Steele R, et al. Anti-miR-203 suppresses ER-positive breast cancer growth and stemness by targeting SOCS3. Oncotarget. 2016 Sep 6; 7(36):58595–58605.
   PubMedGoogle Scholar
• Wu YH, Huang YF, Chang TH, et al. miR-335 restrains the aggressive phenotypes of ovarian cancer cells by inhibiting COL11A1. Cancers (Basel). 2021 Dec 13;13(24):6257.
   PubMed Web of Science ®Google Scholar
• Boukrout N, Souidi M, Lahdaoui F, et al. Antagonistic Roles of the Tumor Suppressor miR-210-3p and Oncomucin MUC4 Forming a Negative Feedback Loop in Pancreatic Adenocarcinoma. Cancers (Basel). 2021 Dec 9;13(24):6197.
   PubMed Web of Science ®Google Scholar
• Zhang M, Jiang D, Xie X, et al. miR-129-3p inhibits NHEJ pathway by targeting SAE1 and represses gastric cancer progression. Int J Clin Exp Pathol. 2019;12(5):1539–1547.
   PubMed Web of Science ®Google Scholar
• Fu R, Yang P, Sajid A, et al. Avenanthramide A induces cellular senescence via miR-129-3p/Pirh2/p53 signaling pathway to suppress colon cancer growth. J Agric Food Chem. 2019 May 1; 67(17):4808–4816.
   PubMed Web of Science ®Google Scholar
• Cui S, Zhang K, Li C, et al. Methylation-associated silencing of microRNA-129-3p promotes epithelial-mesenchymal transition, invasion and metastasis of hepatocelluar cancer by targeting Aurora-A. Oncotarget. 2016 Nov 22;7(47):78009–78028.
   PubMedGoogle Scholar
• Bijnsdorp IV, Hodzic J, Lagerweij T, et al. miR-129-3p controls centrosome number in metastatic prostate cancer cells by repressing CP110. Oncotarget. 2016 Mar 29;7(13):16676–16687.
   PubMedGoogle Scholar
• Zhang Y, Wang Y, Wei Y, et al. MiR-129-3p promotes docetaxel resistance of breast cancer cells via CP110 inhibition. Sci Rep. 2015 Oct 21;5(1):15424.
   PubMedGoogle Scholar
• Ma S, Kong S, Wang F, et al. CircRNAs: biogenesis, functions, and role in drug-resistant tumours. Mol Cancer. 2020 Aug 5; 19(1):119.
   PubMed Web of Science ®Google Scholar
• Huang JL, Su M, Wu DP. Functional roles of circular RNAs in Alzheimer’s disease. Ageing Res Rev. 2020 Jul;60:101058.
   PubMed Web of Science ®Google Scholar
• Li J, Sun D, Pu W, et al. Circular RNAs in cancer: biogenesis, function, and clinical significance. Trends Cancer. 2020 Apr;6(4):319–336.
   PubMed Web of Science ®Google Scholar
• Wu P, Mo Y, Peng M, et al. Emerging role of tumor-related functional peptides encoded by lncRNA and circRNA. Mol Cancer. 2020 Feb 4;19(1):22.
   PubMed Web of Science ®Google Scholar
• Lei M, Zheng G, Ning Q, et al. Translation and functional roles of circular RNAs in human cancer. Mol Cancer. 2020 Feb 15; 19(1):30.
   PubMed Web of Science ®Google Scholar
• Xiao MS, Ai Y, Wilusz JE. Biogenesis and functions of circular RNAs come into focus. Trends Cell Biol. 2020 Mar;30(3):226–240.
   PubMed Web of Science ®Google Scholar
• Hsiao KY, Lin YC, Gupta SK, et al. Noncoding effects of circular RNA CCDC66 promote colon cancer growth and metastasis. Cancer Res. 2017 May 1;77(9):2339–2350.
   PubMed Web of Science ®Google Scholar
• Yang J, Yang L, Li S, et al. HGF/c-Met promote renal carcinoma cancer stem cells enrichment through upregulation of Cir-CCDC66. Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033819901114.
   Web of Science ®Google Scholar
• Qi L, Wang W, Zhao G, et al. Circular RNA circCCDC66 promotes glioma proliferation by acting as a ceRNA for miR-320a to regulate FOXM1 expression. Aging (Albany NY). 2021 Jul 12;13(13):17673–17689.
   PubMedGoogle Scholar
• Zhang Y, Li X, Zhang J, et al. Circ-CCDC66 upregulates REXO1 expression to aggravate cervical cancer progression via restraining miR-452-5p. Cancer Cell Int. 2021 Jan 6; 21(1):20.
   PubMed Web of Science ®Google Scholar
• Federico C, Sun J, Muz B, et al. Localized delivery of cisplatin to cervical cancer improves its therapeutic efficacy and minimizes its side effect profile. Int J Radiat Oncol Biol Phys. 2021 Apr 1;109(5):1483–1494.
   PubMed Web of Science ®Google Scholar
• Suhail M, Tarique M, Muhammad N, et al. A critical transcription factor NF-kappaB as a cancer therapeutic target and its inhibitors as cancer treatment options. Curr Med Chem. 2021;28(21):4117–4132.
   PubMed Web of Science ®Google Scholar
• Floberg JM, Zhang J, Muhammad N, et al. Standardized uptake value for (18)F-Fluorodeoxyglucose is a marker of inflammatory state and immune infiltrate in cervical cancer. Clin Cancer Res. 2021 Aug 1;27(15):4245–4255.
   PubMed Web of Science ®Google Scholar
• Rashmi R, Jayachandran K, Zhang J, et al. Glutaminase inhibitors induce thiol-mediated oxidative stress and radiosensitization in treatment-resistant cervical cancers. Mol Cancer Ther. 2020 Dec;19(12):2465–2475.
   PubMed Web of Science ®Google Scholar
• Singh SV, Chaube B, Mayengbam SS, et al. Metformin induced lactic acidosis impaired response of cancer cells towards paclitaxel and doxorubicin: role of monocarboxylate transporter. Biochim Biophys Acta Mol Basis Dis. 2021 Mar 1;1867(3):166011.
   PubMed Web of Science ®Google Scholar
• Cen Y, Zhu T, Zhang Y, et al. hsa_circ_0005358 suppresses cervical cancer metastasis by interacting with PTBP1 protein to destabilize CDCP1 mRNA. Mol Ther Nucleic Acids. 2022 Mar 8;27:227–240.
   PubMedGoogle Scholar
• Cheng Z, Yu C, Cui S, et al. circTP63 functions as a ceRNA to promote lung squamous cell carcinoma progression by upregulating FOXM1. Nat Commun. 2019 Jul 19;10(1):3200.
   PubMed Web of Science ®Google Scholar
• Chioccarelli T, Falco G, Cappetta D, et al. FUS driven circCNOT6L biogenesis in mouse and human spermatozoa supports zygote development. Cell Mol Life Sci. 2021 Dec 22;79(1):50.
   PubMed Web of Science ®Google Scholar
• Niu R, Li D, Chen J, et al. Circ_0014235 confers Gefitinib resistance and malignant behaviors in non-small cell lung cancer resistant to Gefitinib by governing the miR-146b-5p/YAP/PD-L1 pathway. Cell Cycle. 2021 Dec;17:1–15.
   Google Scholar
• Callaghan MM, Koch B, Hackett KT, et al. Expression, localization, and protein interactions of the partitioning proteins in the gonococcal type IV secretion system. Front Microbiol. 2021;12:784483.
   PubMed Web of Science ®Google Scholar
• Chen Z, Zheng Z, Xie Y, et al. Circular RNA circPPP6R3 upregulates CD44 to promote the progression of clear cell renal cell carcinoma via sponging miR-1238-3p. Cell Death Dis. 2021 Dec 21;13(1):22.
   PubMed Web of Science ®Google Scholar
• Min X, Cai MY, Shao T, et al. A circular intronic RNA ciPVT1 delays endothelial cell senescence by regulating the miR-24-3p/CDK4/pRb axis. Aging Cell. 2021 Dec 13;21(1):e13529.
   PubMed Web of Science ®Google Scholar
• Yuan Y, Yan G, He M, et al. ALKBH5 suppresses tumor progression via an m(6)A-dependent epigenetic silencing of pre-miR-181b-1/YAP signaling axis in osteosarcoma. Cell Death Dis. 2021 Jan 11;12(1):60.
   PubMed Web of Science ®Google Scholar
• Ji Y, Yang S, Yan X, et al. CircCRIM1 promotes hepatocellular carcinoma proliferation and angiogenesis by sponging miR-378a-3p and regulating SKP2 expression. Front Cell Dev Biol. 2021;9:796686.
   PubMed Web of Science ®Google Scholar
• Shang BQ, Li ML, Quan HY, et al. Functional roles of circular RNAs during epithelial-to-mesenchymal transition. Mol Cancer. 2019 Sep 16;18(1):138.
   PubMed Web of Science ®Google Scholar
• Shan C, Zhang Y, Hao X, et al. Biogenesis, functions and clinical significance of circRNAs in gastric cancer. Mol Cancer. 2019 Sep 13; 18(1):136.
   PubMed Web of Science ®Google Scholar
• Li Z, Huang X, Liu A, et al. Circ_PSD3 promotes the progression of papillary thyroid carcinoma via the miR-637/HEMGN axis. Life Sci. 2020 Oct 22;264:118622.
   PubMed Web of Science ®Google Scholar
• Wang YF, Li MY, Tang YF, et al. Circular RNA circEIF3I promotes papillary thyroid carcinoma progression through competitively binding to miR-149 and upregulating KIF2A expression. Am J Cancer Res. 2020;10(4):1130–1139.
   PubMed Web of Science ®Google Scholar
• Yao Y, Chen X, Yang H, et al. Hsa_circ_0058124 promotes papillary thyroid cancer tumorigenesis and invasiveness through the NOTCH3/GATAD2A axis. J Exp Clin Cancer Res. 2019 Jul 19;38(1):318.
   PubMedGoogle Scholar
• Wu D, Zhu J, Fu Y, et al. LncRNA HOTAIR promotes breast cancer progression through regulating the miR-129-5p/FZD7 axis. Cancer Biomark. 2020 Oct 13.
   Web of Science ®Google Scholar
• Wu L, Zhu X, Song Z, et al. FGD5-AS1 facilitates glioblastoma progression by activation of Wnt/beta-catenin signaling via regulating miR-129-5p/HNRNPK axis. Life Sci. 2020 Sep 1; 256:117998
   PubMed Web of Science ®Google Scholar
• Yu J, Zhang X, Ma Y, et al. MiR-129-5p restrains apatinib resistance in human gastric cancer cells via downregulating HOXC10. Cancer Biother Radiopharm. 2020 Jun 16;36(1):95–105.
   PubMed Web of Science ®Google Scholar
• He J, Ge Q, Lin Z, et al. MiR-129-5p induces cell cycle arrest through modulating HOXC10/Cyclin D1 to inhibit gastric cancer progression. FASEB J. 2020 Jun;34(6):8544–8557.
   PubMed Web of Science ®Google Scholar
• Xu C, Du Z, Ren S, et al. MiR-129-5p sensitization of lung cancer cells to etoposide-induced apoptosis by reducing YWHAB. J Cancer. 2020;11(4):858–866.
   PubMed Web of Science ®Google Scholar
• Liao C, Long Z, Zhang X, et al. LncARSR sponges miR-129-5p to promote proliferation and metastasis of bladder cancer cells through increasing SOX4 expression. Int J Biol Sci. 2020;16(1):1–11.
   PubMed Web of Science ®Google Scholar
• Wu C, Miao C, Tang Q, et al. MiR-129-5p promotes docetaxel resistance in prostate cancer by down-regulating CAMK2N1 expression. J Cell Mol Med. 2020 Feb;24(3):2098–2108.
   PubMed Web of Science ®Google Scholar
• Zhang H, Cai Y, Zheng L, et al. Long noncoding RNA NEAT1 regulate papillary thyroid cancer progression by modulating miR-129-5p/KLK7 expression. J Cell Physiol. 2018 Oct;233(10):6638–6648.
   PubMed Web of Science ®Google Scholar
• Fonseca BD, Lahr RM, Damgaard CK, et al. LARP1 on TOP of ribosome production. Wiley Interdiscip Rev RNA. 2018 May 2.
   PubMed Web of Science ®Google Scholar
• Deragon JM, Bousquet-Antonelli C. The role of LARP1 in translation and beyond. Wiley Interdiscip Rev RNA. 2015 Jul-Aug;6(4):399–417.
   PubMed Web of Science ®Google Scholar
• Hong S, Freeberg MA, Han T, et al. LARP1 functions as a molecular switch for mTORC1-mediated translation of an essential class of mRNAs. Elife. 2017 Jun 26;6: 10.7554/eLife.25237
   Web of Science ®Google Scholar
• Fonseca BD, Zakaria C, Jia JJ, et al. La-related protein 1 (LARP1) represses terminal oligopyrimidine (TOP) mRNA translation downstream of mTOR complex 1 (mTORC1). J Biol Chem. 2015 Jun 26;290(26):15996–16020.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Cai W, Zou Y, et al. Knockdown of KCNQ1OT1 inhibits proliferation, invasion, and drug resistance by regulating miR-129-5p-Mediated LARP1 in osteosarcoma. Biomed Res Int. 2020;2020:7698767.
   PubMed Web of Science ®Google Scholar
• Han J, Zhao G, Ma X, et al. CircRNA circ-BANP-mediated miR-503/LARP1 signaling contributes to lung cancer progression. Biochem Biophys Res Commun. 2018 Sep 18;503(4):2429–2435.
   PubMed Web of Science ®Google Scholar
• Xu Z, Xu J, Lu H, et al. LARP1 is regulated by the XIST/miR-374a axis and functions as an oncogene in non-small cell lung carcinoma. Oncol Rep. 2017 Dec;38(6):3659–3667.
   PubMed Web of Science ®Google Scholar
• Ye L, Lin S-T, Mi Y-S, et al. Overexpression of LARP1 predicts poor prognosis of colorectal cancer and is expected to be a potential therapeutic target. Tumour Biol. 2016 Nov;37(11):14585–14594.
   PubMedGoogle Scholar
• Hopkins TG, Mura M, Al-Ashtal HA, et al. The RNA-binding protein LARP1 is a post-transcriptional regulator of survival and tumorigenesis in ovarian cancer. Nucleic Acids Res. 2016 Feb 18;44(3):1227–1246.
   PubMed Web of Science ®Google Scholar